Toxic epidermal necrolysis: a paradigm of critical illness.

about

Toxic epidermal necrolysis: a paradigm of critical illness.

Item

http://www.wikidata.org/entity/Q49468674

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Toxic epidermal necrolysis: a paradigm of critical illness.

@en

Toxic epidermal necrolysis: a paradigm of critical illness.

@nl

type

Item

label

Toxic epidermal necrolysis: a paradigm of critical illness.

@en

Toxic epidermal necrolysis: a paradigm of critical illness.

@nl

prefLabel

Toxic epidermal necrolysis: a paradigm of critical illness.

@en

Toxic epidermal necrolysis: a paradigm of critical illness.

@nl

P1476

Toxic epidermal necrolysis: a paradigm of critical illness.

@en

P2093

Alfonso Estrella-Alonso

http://www.w3.org/2001/XMLSchema#string

José A Lorente

http://www.w3.org/2001/XMLSchema#string

José Antonio Aramburu

http://www.w3.org/2001/XMLSchema#string

Lucía Cachafeiro

http://www.w3.org/2001/XMLSchema#string

Manuel Sánchez Sánchez

http://www.w3.org/2001/XMLSchema#string

Mercedes Yolanda González-Ruiz

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study.

Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.

Severe adverse cutaneous reactions to drugs.

Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

P304

499-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.5935/0103-507X.20170075

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29340540

http://www.w3.org/2001/XMLSchema#string

P921

Stevens-Johnson syndrome

critical illness

P932

5764563

http://www.w3.org/2001/XMLSchema#string